Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
clinical trials
drugs
2
×
life sciences
national blog main
alirocumab
allergan
alnylam pharmaceuticals
amgen
boston
boston top stories
crispr
cynthia collins
editas medicine
evercore isi
evolocumab
gene editing
heart attack
inclisiran
joseph swartz
katrine bosley
leber congenital amaurosis
medicines co.
new york
new york blog main
new york top stories
pcsk9 inhibitors
regeneron pharmaceuticals
rna interference
stroke
svb leerink
umer raffat
What
partner
2
×
allergan
alnylam
based
blessing
bosley
ceo
check
cholesterol
clinical
crispr
cusp
data
depart
drug
editas
editing
evidence
experimental
gene
heart
humans
katrine
lasting
long
looms
lowering
medco
medicine
medicines
million
new
pharmaceuticals
presented
reckoning
regulatory
rna
supporting
term
test
Language
Current search:
partner
×
drugs
×
@xconomy.com
4 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial